NCT02755974Recruiting
The London COPD Exacerbation Cohort
Relationship Between Patient Phenotypes and Exacerbations in Chronic Obstructive Pulmonary Disease.
Source: ClinicalTrials.gov · Last updated 21 Jun 2022 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The London COPD exacerbation (EXCEL) cohort builds on an established cohort started in 1995 and designed to study COPD exacerbations and their impact on health-status and disease progression.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 300 (estimated)
- First submitted
- 13 Apr 2016
- Start date
- Jan 2009
- Primary completion date
- Dec 2026
- Lead sponsor
- Imperial College London
- Diseases
- COPD
- NCT number
- NCT02755974
What you commit to
- Study type: Observational
- Planned participants: 300
- From Jan 2009 to the primary completion date, Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Long term steroid therapy
Other illness
- Patients with a history of asthma, bronchiectasis, carcinoma of the bronchus, or other significant respiratory disease were excluded.
- Patients on Immunosuppressive medications or with active cancer
Age
- Age \<40 years at recruitment
Who the study is looking for
- Forced Expiratory Volume in 1 sec (FEV1)/Forced Vital Capacity (FVC) ratio of \<0.70
- Able and willing to give informed and written consent
Age in the registry: 40 years to 100 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| National Heart and Lung Institute, Imperial College Coordinator of this site? Confirm its status | London | United Kingdom | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.